Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$127.59 - $203.08 $64,432 - $102,555
-505 Reduced 29.6%
1,201 $243,000
Q4 2022

Feb 09, 2023

SELL
$117.37 - $139.17 $78,990 - $93,661
-673 Reduced 28.29%
1,706 $219,000
Q3 2022

Nov 14, 2022

SELL
$135.27 - $180.11 $732,622 - $975,475
-5,416 Reduced 69.48%
2,379 $325,000
Q2 2022

Aug 05, 2022

SELL
$108.81 - $179.33 $810,090 - $1.34 Million
-7,445 Reduced 48.85%
7,795 $1.38 Million
Q1 2022

May 11, 2022

SELL
$119.61 - $157.85 $67,220 - $88,711
-562 Reduced 3.56%
15,240 $2.2 Million
Q4 2021

Feb 11, 2022

SELL
$142.57 - $190.86 $248,642 - $332,859
-1,744 Reduced 9.94%
15,802 $1.97 Million
Q3 2021

Nov 16, 2021

BUY
$142.45 - $169.82 $130,769 - $155,894
918 Added 5.52%
17,546 $2.98 Million
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $98,068 - $116,958
726 Added 4.57%
16,628 $2.63 Million
Q1 2021

Jun 16, 2021

BUY
$137.51 - $190.8 $168,587 - $233,920
1,226 Added 8.35%
15,902 $2.21 Million
Q4 2020

Jan 25, 2021

BUY
$164.63 - $211.93 $2.42 Million - $3.11 Million
14,676 New
14,676 $2.59 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Nia Impact Advisors, LLC Portfolio

Follow Nia Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nia Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nia Impact Advisors, LLC with notifications on news.